| Dr Gwen L David, MD | |
|
95 Northfield Ave, West Orange, NJ 07052-4723 | |
| (973) 736-4505 | |
| (973) 736-9066 |
| Full Name | Dr Gwen L David |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 95 Northfield Ave, West Orange, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225138308 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MA055664 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gwen L David, MD Po Box 22581, New York, NY 10087-2581 Ph: (610) 482-4795 | Dr Gwen L David, MD 95 Northfield Ave, West Orange, NJ 07052-4723 Ph: (973) 736-4505 |
News Archive
One of the most effective measures for containing the transmission of a virus is to identify who an infected person has been in contact and/or crossed paths with, mainly during incubation periods.
Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure. Amturnide combines the only approved direct renin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).
Watson Pharmaceuticals, Inc. today announced that the results of an open-label extension of two Phase 3 studies, published in the December issue of the peer-reviewed journal Urology, demonstrate long-term safety and tolerability of RAPAFLO® (silodosin) for up to 52 weeks of treatment. RAPAFLO® is an effective and uniquely selective alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), the number one reason patients visit urologists.
Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces the initiation of two pivotal Phase 3 studies of APD421 in the prevention of post-operative nausea & vomiting (PONV).
Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is pleased to announce its President & CEO, Mr. Raymond C. Dabney, along with CBIS's Senior Scientific Advisor, Dr. Roscoe M. Moore, Jr., have initiated a partnership between CBIS and the Constituency for Africa to help improve the healthcare and health-related education infrastructure in Africa.
› Verified 2 days ago
Dr. Gerald F Ciciola Jr., MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 95 Northfield Ave, West Orange, NJ 07052 Phone: 973-736-4505 Fax: 973-736-9066 | |
Dr. William Michael Steck, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 737 Northfield Ave, West Orange, NJ 07052 Phone: 973-731-1800 Fax: 973-731-6196 | |
Claudine M. Sylvester, M. D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 520 Pleasant Valley Way, West Orange, NJ 07052 Phone: 973-669-5711 Fax: 973-669-5722 | |
Dr. Alex G Popko, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Old Short Hills Road, Suite 101, West Orange, NJ 07052 Phone: 973-736-1100 | |
Mr. Stephen Crane, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 375 Mount Pleasant Ave, Suite 202, West Orange, NJ 07052 Phone: 973-731-7707 Fax: 973-669-0277 | |
Mrs. Vivian S Lo, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 520 Pleasant Valley Way, West Orange, NJ 07052 Phone: 973-669-5711 Fax: 973-669-5722 | |
Dr. Daniel Sansobrino, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 375 Mount Pleasant Ave, West Orange, NJ 07052 Phone: 973-731-7707 Fax: 973-669-0277 |